VYCO
Vycor Medical, Inc.

Vycor Medical’s FDA-cleared ViewSite™ Brain Access System (VBAS) a minimally invasive neurosurgical device designed to improve access to brain lesions while reducing tissue damage and enhancing patient outcomes. The VBAS system has been approved and used in over 300 hospitals in the US and in numerous countries internationally. VBAS is protected by 46 issued and 11 pending patents and has been validated through 43 peer-reviewed studies. These studies demonstrate: less brain tissue damage; less invasive procedure; improved access and better visibility; and reduced operating and recovery time. NovaVision provides a suite of clinically supported vision rehabilitation therapies to help patients recover from visual impairments caused by stroke or other brain injury. The Visual Restoration Therapy (VRT) is the only commercialized FDA-cleared therapy for this type of vision rehabilitation, making it a unique and important option for patients seeking to regain lost visual capabilities. The complementary NeuroEyeCoach program, clinically supported by a 296-patient study (the largest to date in the neuro visual space), enables dramatic improvements in patients’ ability to detect objects in the visual field by training them to make better eye movements with improvement in over 80% of patients. The NovaVision therapies, while showing a positive impact on these patients’ lives, still require significant development to allow them to successfully address their market potential

The company leases its headquarters office space located in Boca Raton. Vycor partners with qualified subcontract manufacturers to produce its medical devices